• This is the PPA version of the course. If you would prefer to take the non-PPA version of the course please click here

    Faculty

    • Professor Patrick Vermersch, Vice Dean, University of Lille, CHRU de Lille, Lille International Research Inflammation Centre (LIRIC), Lille, France
    • Professor Antonio Uccelli, Professor of Neurology, Department of Neurology, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), Università di Genova, Italy
    • Professor Tobias Derfuss, Professor of Medicine and Senior Physician, Departments of Neurology and Biomedicine at University Clinic, Basel, Switzerland
    • Professor Gavin Giovannoni, Chair of Neurology, Blizard Institute, Queen Mary University of London, London, United Kingdom

    Course overview

    The programme first establishes your current practice, takes you through a six module e-learning course (including content from the UEMS/EACCME-accredited meeting “Integrating Innovations in the Treatment of Multiple Sclerosis into Clinical Practice”) and then provides a structured, self-reflective tool to help you implement new treatment strategies in your own clinical practice

    Target audience

    This educational activity is intended for any healthcare professionals involved in the treatment of patients with multiple sclerosis

    Learning objectives

    Upon completing of the programme, participants should be able to:

    • Understand the evolution of the multiple sclerosis treatment landscape over the last 25 years, in particular how our evolving understanding of the disease has guided the development of new therapies
    • Describe the current and new strategies for treating multiple sclerosis, including the use of new agents
    • Identify the risks and benefits of these newer treatment strategies and reflect on your own patient interactions, in comparison to your peers, when implementing them in daily practice

    Funding

    This programme has been partly supported by an independent educational grant from Merck KGaA, Darmastadt, Germany

    Accreditation statement

    The e-learning course, Supporting the implementation of new treatment strategies in MS into clinical practice, developed and organized by Clinically Current, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 2 European CME credits (ECMEC®s) to provide the following CME activity for medical specialists. Each medical specialist should claim only those hours of credit that he/she actually spent on the educational materials.

    The EACCME® is an institution of the European Union of Medical Specialists (UEMS). Through an agreement between the European Union of Medical Specialists (UEMS) and the American Medical Association (AMA), physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM.

    Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.

    EACCME